Malignant pleural effusion (MPE) and malignant pleural disease (MPD) are common complications of cancer. Although they may significantly affect the quality of life, treatment options remain limited. Official guidelines recommend effusion drainage and pleurodesis, and, while they may achieve symptomatic relief, their impact on disease progression is limited. Intrapleural therapy has been studied for several decades due to its theoretical (and proven) superior local drug retention, maximising drug exposure. Recent works on intrapleural administration include exploring novel therapeutic agents and administration methods, such as hyperthermic intrathoracic chemotherapy (HITHOC) and pressurised intrathoracic chemotherapy (PITAC). These therapies directly modulate the tumour environments. Promising intrapleural candidates include targeted and immunotherapies such as CAR (chimeric antigen receptor)-T cells, PD-1 (programmed death protein 1) inhibitors, and IL-6 (interleukin-6) inhibitors. However, the level of evidence remains mixed, requiring further studies and quantitative synthesis.
Advances on the Intrapleural Management of Malignant Pleural Disease. // The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. – 2026. – DOI: 10.1007/s41030-026-00403-9. – URL: https://link.springer.com/article/10.1007/s41030-026-00403-9
(2026). Advances on the Intrapleural Management of Malignant Pleural Disease. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. https://doi.org/10.1007/s41030-026-00403-9
“Advances on the Intrapleural Management of Malignant Pleural Disease.” The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2026. doi:10.1007/s41030-026-00403-9.
@article{article35045,
title = {Advances on the Intrapleural Management of Malignant Pleural Disease},
journal = {The Egyptian Journal of Neurology, Psychiatry and Neurosurgery},
year = {2026},
doi = {10.1007/s41030-026-00403-9},
url = {https://link.springer.com/article/10.1007/s41030-026-00403-9}
}
Purpose The engineered v5.9 DNA polymerase has been reported to exhibit enhanced thermostability in loop-mediated isothermal amplification (LAMP). As an initial step toward field-deployable molecular diagnosis of giardiasis, we...
Background Polygenic risk scores for cardiovascular disease show poor agreement between methods, and most treat sex as a covariate rather than stratifying by it, despite well-documented sex differences in disease incidence and outcomes....
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Cognitive tests are commonly used to evaluate the effects of cognitive and exercise interventions in Parkinson’s disease, but their ability to distinguish genuine change from measurement variability remains insufficiently characterized....